TP53 and cancer: Several studies have reported the simultaneous occurrence of both miR-21 overexpression and p53 functional impairment in some cancer types, and miR-21 could inhibit the activity or expression level of many genes in p53 signaling network [24–26], which suggested a possible interaction between miR-21 and p53.